(Reuters) -The European Union's drugs regulator on Thursday recommended approval for Eisai and Biogen's Leqembi in some ...
The agency's new guidelines require drugmakers to provide viewers with a clearer picture of medications' risks and side effects. Congress also is looking at giving the FDA authority to regulate drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback